CRESUD S.A.-SPONS ADR (CRESY)

US2264061068 - ADR

11.37  +0.13 (+1.16%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CRESY. CRESY was compared to 91 industry peers in the Food Products industry. CRESY has a medium profitability rating, but doesn't score so well on its financial health evaluation. CRESY does not seem to be growing, but still is valued expensively.



5

1. Profitability

1.1 Basic Checks

Of the past 5 years CRESY 4 years were profitable.
CRESY had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of 1.22%, CRESY perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
CRESY has a Return On Equity (6.03%) which is in line with its industry peers.
CRESY has a Return On Invested Capital of 5.55%. This is comparable to the rest of the industry: CRESY outperforms 55.56% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRESY is significantly below the industry average of 8.93%.
The 3 year average ROIC (2.55%) for CRESY is below the current ROIC(5.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.22%
ROE 6.03%
ROIC 5.55%
ROA(3y)4.46%
ROA(5y)1.27%
ROE(3y)25.84%
ROE(5y)3.92%
ROIC(3y)2.55%
ROIC(5y)1.98%

1.3 Margins

The Profit Margin of CRESY (4.80%) is better than 68.89% of its industry peers.
CRESY's Operating Margin of 22.19% is amongst the best of the industry. CRESY outperforms 97.78% of its industry peers.
CRESY's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 37.69%, CRESY belongs to the best of the industry, outperforming 85.56% of the companies in the same industry.
CRESY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 22.19%
PM (TTM) 4.8%
GM 37.69%
OM growth 3Y103.59%
OM growth 5Y-0.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.68%
GM growth 5Y-1.65%

2

2. Health

2.1 Basic Checks

CRESY has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CRESY has been increased compared to 5 years ago.
CRESY has a better debt/assets ratio than last year.

2.2 Solvency

A Debt/Equity ratio of 0.77 indicates that CRESY is somewhat dependend on debt financing.
CRESY has a Debt to Equity ratio of 0.77. This is in the lower half of the industry: CRESY underperforms 65.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.09 indicates that CRESY should not have too much problems paying its short term obligations.
CRESY has a worse Current ratio (1.09) than 73.33% of its industry peers.
CRESY has a Quick Ratio of 1.09. This is a bad value and indicates that CRESY is not financially healthy enough and could expect problems in meeting its short term obligations.
CRESY's Quick ratio of 0.85 is in line compared to the rest of the industry. CRESY outperforms 42.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.85

3

3. Growth

3.1 Past

The earnings per share for CRESY have decreased strongly by -71.30% in the last year.
The Revenue has grown by 187.37% in the past year. This is a very strong growth!
The Revenue has been growing by 71.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-71.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168.66%
Revenue 1Y (TTM)187.37%
Revenue growth 3Y68.04%
Revenue growth 5Y71.8%
Sales Q2Q%193.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.15%, CRESY is a good candidate for dividend investing.
CRESY's Dividend Yield is rather good when compared to the industry average which is at 3.79. CRESY pays more dividend than 98.89% of the companies in the same industry.
CRESY's Dividend Yield is rather good when compared to the S&P500 average which is at 2.19.
Industry RankSector Rank
Dividend Yield 10.15%

5.2 History

CRESY has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of CRESY decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2

5.3 Sustainability

CRESY pays out 273.94% of its income as dividend. This is not a sustainable payout ratio.
DP273.94%
EPS Next 2YN/A
EPS Next 3YN/A

CRESUD S.A.-SPONS ADR

NASDAQ:CRESY (11/22/2024, 8:00:00 PM)

11.37

+0.13 (+1.16%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap671.16M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 10.15%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.22%
ROE 6.03%
ROCE
ROIC
ROICexc
ROICexgc
OM 22.19%
PM (TTM) 4.8%
GM 37.69%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.09
Quick Ratio 0.85
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-71.3%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)187.37%
Revenue growth 3Y68.04%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y